In general, miR-16 was described as an miR with tumor suppressor functions, was involved in the regulation of MHC molecules, and was downregulated in blood samples from various tumor entities and in tumor cell lines [34,35,36]. The gene discussed is HLA-C; the disease is neoplasm.